Wide-Bandwidth Open Canal Hearing Aid For Better Multitalker Speech Understanding
2 other identifiers
interventional
16
1 country
1
Brief Summary
Our goal is to design and build a new hearing aid system, which mitigates the most common complaints that hearing aid users have. These include hearing in multi-talker situations, poor sound quality, unwanted whistling resulting from feedback, and a dislike of the sound of their own voice. Current efforts, with limited success, use signal processing methods rather than restoring more closely the normal auditory function. We plan to achieve our goal by reducing to practice three key enabling concepts. The first is to replace the current acoustic transducer with a non-acoustic mechanical output transducer that directly actuates the tympanic membrane (TM). This transducer, called the EarLens, floats on the tympanic membrane in a manner similar to the way a contract lens floats on the eye. The second is to increase the output bandwidth of the hearing aid. The third key concept is to place a wide-bandwidth microphone in the ear canal to capture the pinna diffraction cues similarly to the way the normal ear functions. Our central hypothesis is that a hearing aid that delivers amplified wide-bandwidth mechanical stimuli, directionally dependent cues, in an open canal configuration will perform better than conventional hearing aids when there are competing talkers in the background. First phase includes verification the capability of the system to deliver sufficient maximum equivalent pressure output (MEPO) to treat the degree of hearing loss in the target fitting range.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for phase_1
Started May 2006
Typical duration for phase_1
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedFirst Submitted
Initial submission to the registry
December 19, 2007
CompletedFirst Posted
Study publicly available on registry
December 28, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2009
CompletedResults Posted
Study results publicly available
October 3, 2016
CompletedNovember 4, 2016
September 1, 2016
3.6 years
December 19, 2007
October 29, 2013
September 30, 2016
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Maximum Effective Sound Pressure Level (MEPO)
A primary outcome measure of interest is an estimate of the insitu maximum equivalent pressure output (MEPO) of the EarLens system, which represents the sound pressure level that would have to be applied at the eardrum (or tympanic membrane) to produce the same degree of tympanic membrane (TM) vibration that the EarLens system produces with the coil current set to its maximum value, and given the anatomical constraints on the coupling between the coil and magnet for a given subject. The target fitting range included hearing loss up to 60 decibels (dB) Hearing Level (HL). In order for the device to be an effective hearing aid for this target population, the maximum output of the device needs to be able to provide output and gain to treat this maximum hearing loss.
1 month
Study Arms (1)
Magnetic Contact Hearing Aid
EXPERIMENTALSubjects were treated with a hearing aid which provided amplification intended to treat mild to moderate sensorineural hearing loss. Acute performance and safety assessed at 4 months compared to unaided baseline pre-treatment, followed by longer-term assessment of safety up to 10 months.
Interventions
Subjects were treated with a hearing aid which provided amplification intended to treat mild to moderate sensorineural hearing loss.
Eligibility Criteria
You may qualify if:
- Hearing loss less than 60 dB at any frequency, no conductive hearing loss
You may not qualify if:
- Collapsed ear canal, damaged or repaired middle ear, too much sensory hearing loss
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ear Lens Corporation
Redwood City, California, 94063, United States
Related Publications (1)
Perkins R, Fay JP, Rucker P, Rosen M, Olson L, Puria S. The EarLens system: new sound transduction methods. Hear Res. 2010 May;263(1-2):104-13. doi: 10.1016/j.heares.2010.01.012. Epub 2010 Jan 29.
PMID: 20116419RESULT
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Results Point of Contact
- Title
- Sunil Puria
- Organization
- EarLens Corporation
Study Officials
- PRINCIPAL INVESTIGATOR
Sunil Puria
Ear Lens Corporation
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 1
- Allocation
- NA
- Masking
- NONE
- Purpose
- BASIC SCIENCE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- INDUSTRY
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Director of Clinical, For Sunil Puria, Chief Scientist (no longer with company)
Study Record Dates
First Submitted
December 19, 2007
First Posted
December 28, 2007
Study Start
May 1, 2006
Primary Completion
December 1, 2009
Study Completion
December 1, 2009
Last Updated
November 4, 2016
Results First Posted
October 3, 2016
Record last verified: 2016-09
Data Sharing
- IPD Sharing
- Will not share
Please see publication for summary results.